Refining the relationship between gut microbiota and common hematologic malignancies: insights from a bidirectional Mendelian randomization study
- PMID: 38975324
- PMCID: PMC11224959
- DOI: 10.3389/fcimb.2024.1412035
Refining the relationship between gut microbiota and common hematologic malignancies: insights from a bidirectional Mendelian randomization study
Abstract
Background: The relationship between gut microbiota and hematologic malignancies has attracted considerable attention. As research progresses, it has become increasingly clear that the composition of gut microbiota may influence the onset and progression of hematologic malignancies. However, our understanding of this association remains limited.
Methods: In our study, we classified gut microbiota into five groups based on information at the phylum, class, order, family, and genus levels. Subsequently, we obtained data related to common hematologic malignancies from the IEU Open GWAS project. We then employed a bidirectional Mendelian Randomization (MR) approach to determine whether there is a causal relationship between gut microbiota and hematologic malignancies. Additionally, we conducted bidirectional MR analyses to ascertain the directionality of this causal relationship.
Results: Through forward and reverse MR analyses, we found the risk of lymphoid leukemia was significantly associated with the abundance of phylum Cyanobacteria, order Methanobacteriales, class Methanobacteria, family Peptococcaceae, family Methanobacteriaceae, and genera Lachnospiraceae UCG010, Methanobrevibacter, Eubacterium brachy group, and Butyrivibrio. The risk of myeloid leukemia was significantly associated with the abundance of phylum Actinobacteria, phylum Firmicutes, order Bifidobacteriales, order Clostridiales, class Actinobacteria, class Gammaproteobacteria, class Clostridia, family Bifidobacteriaceae, and genera Fusicatenibacter, Eubacterium hallii group, Blautia, Collinsella, Ruminococcus gauvreauii group, and Bifidobacterium. The risk of Hodgkin lymphoma was significantly associated with the abundance of family Clostridiales vadinBB60 group, genus Peptococcus, and genus Ruminococcaceae UCG010. The risk of malignant plasma cell tumor was significantly associated with the abundance of genera Romboutsia and Eubacterium rectale group. The risk of diffuse large B-cell lymphoma was significantly associated with the abundance of genera Erysipelatoclostridium and Eubacterium coprostanoligenes group. The risk of mature T/NK cell lymphomas was significantly associated with the abundance of phylum Verrucomicrobia, genus Ruminococcaceae UCG013, genus Lachnoclostridium, and genus Eubacterium rectale group. Lastly, the risk of myeloproliferative neoplasms was significantly associated with the abundance of genus Coprococcus 3 and Eubacterium hallii group.
Conclusion: Our study provided new evidence for the causal relationship between gut microbiota and hematologic malignancies, offering novel insights and approaches for the prevention and treatment of these tumors.
Keywords: IVW; MR; SNPs; gut microbiota; hematologic malignancies.
Copyright © 2024 Chen, Guo, Wang, Feng, Qin, Hu, Lyu and Wang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures





Similar articles
-
A Large Genetic Causal Analysis of the Gut Microbiota and Urological Cancers: A Bidirectional Mendelian Randomization Study.Nutrients. 2023 Sep 21;15(18):4086. doi: 10.3390/nu15184086. Nutrients. 2023. PMID: 37764869 Free PMC article.
-
Association between gut microbiota and malignant cardiac tumors: A two-sample Mendelian randomization study.Cancer Med. 2024 Jul;13(13):e7455. doi: 10.1002/cam4.7455. Cancer Med. 2024. PMID: 38953300 Free PMC article.
-
Genetic liability of gut microbiota for idiopathic pulmonary fibrosis and lung function: a two-sample Mendelian randomization study.Front Cell Infect Microbiol. 2024 May 22;14:1348685. doi: 10.3389/fcimb.2024.1348685. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38841114 Free PMC article.
-
The causal relationships between gut microbiota and venous thromboembolism: a Mendelian randomization study.Hereditas. 2025 Feb 20;162(1):25. doi: 10.1186/s41065-025-00389-5. Hereditas. 2025. PMID: 39980076 Free PMC article.
-
Exploring the potential causal relationship between gut microbiota and heart failure: A two-sample mendelian randomization study combined with the geo database.Curr Probl Cardiol. 2024 Feb;49(2):102235. doi: 10.1016/j.cpcardiol.2023.102235. Epub 2023 Nov 30. Curr Probl Cardiol. 2024. PMID: 38040216 Review.
Cited by
-
Gut Microbiota Disruption in Hematologic Cancer Therapy: Molecular Insights and Implications for Treatment Efficacy.Int J Mol Sci. 2024 Sep 24;25(19):10255. doi: 10.3390/ijms251910255. Int J Mol Sci. 2024. PMID: 39408584 Free PMC article. Review.
-
Commensal Bacteria Drive B-cell Lymphomagenesis in the Setting of Innate Immunodeficiency.Blood Cancer Discov. 2025 Sep 3;6(5):505-525. doi: 10.1158/2643-3230.BCD-24-0279. Blood Cancer Discov. 2025. PMID: 40608826
-
A two-step, two-sample Mendelian randomization analysis investigating the interplay between gut microbiota, immune cells, and melanoma skin cancer.Medicine (Baltimore). 2024 Nov 8;103(45):e40432. doi: 10.1097/MD.0000000000040432. Medicine (Baltimore). 2024. PMID: 39533622 Free PMC article.
-
The causal relationship between circulating inflammatory proteins, gut microbiotas, immune cells and leukemia: a bidirectional Mendelian randomization study.Discov Oncol. 2025 Jun 19;16(1):1157. doi: 10.1007/s12672-025-02863-y. Discov Oncol. 2025. PMID: 40537729 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials